Category: Psychedelic Bulletin - Page 6 - Psychedelic Alpha

Psychedelic Bulletin #143: Trademark Filing Reveals Potential Brand Name for MDMA; DEA “Open to Considering” Special Registration for Controlled Substances via Telemedicine; Professional Practice Guidelines for PAT; Sage’s Zuranolone Rejection

Post published:August 11, 2023
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin #142: Terran’s IP Portfolio; AMA Advocates Against Non-Medical Psychedelics; Couple Receives First Psilocybin Services in Oregon; Mass. Ballot Measure Ramps Up; NIDA and NIMH Directors Opine

Psychedelic Bulletin #142: Terran’s IP Portfolio; AMA Advocates Against Non-Medical Psychedelics; Couple Receives First Psilocybin Services in Oregon; Mass. Ballot Measure Ramps Up; NIDA and NIMH Directors Opine

Post published:July 31, 2023
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin #141: Terran’s 4-OH-DiPT Prodrug Patent App.; Generic Ketamine Appears Effective for TRD; VA/DoD Guideline Reviews Psychedelics

Psychedelic Bulletin #141: Terran’s 4-OH-DiPT Prodrug Patent App.; Generic Ketamine Appears Effective for TRD; VA/DoD Guideline Reviews Psychedelics

Post published:July 17, 2023
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin #140: Regulators Weigh in on Psychedelics; Psychedelic Biotech Strikes Big Pharma Agreement; GH Publishes 5-MeO-DMT Trial

Psychedelic Bulletin #140: Regulators Weigh in on Psychedelics; Psychedelic Biotech Strikes Big Pharma Agreement; GH Publishes 5-MeO-DMT Trial

Post published:June 29, 2023
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin #139: Kentucky Earmarks $42m for Ibogaine Studies; Reunion Announces Take-Private Deal; Compass Patents Upheld; Theories of Psychedelics’ Mechanism of Action

Psychedelic Bulletin #139: Kentucky Earmarks $42m for Ibogaine Studies; Reunion Announces Take-Private Deal; Compass Patents Upheld; Theories of Psychedelics’ Mechanism of Action

Post published:June 14, 2023
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin #138: Delix’s Non-Hallucinogenic Psychedelic Enters the Clinic; Arizona Earmarks $5m for Whole Mushroom Psilocybin Trials; MEPs form EU Action Group

Psychedelic Bulletin #138: Delix’s Non-Hallucinogenic Psychedelic Enters the Clinic; Arizona Earmarks $5m for Whole Mushroom Psilocybin Trials; MEPs form EU Action Group

Post published:May 30, 2023
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin #137: Oregon Approves First Psilocybin Service Centre; AMA Approves Psychedelic CPT Code; MindMed Seeks to Fend Off Proxy Contest

Psychedelic Bulletin #137: Oregon Approves First Psilocybin Service Centre; AMA Approves Psychedelic CPT Code; MindMed Seeks to Fend Off Proxy Contest

Post published:May 8, 2023
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin #136: MindMed Collaborators Share Topline LSD for MDD Results; Oregon Issues Psilocybin Licences; UK Parliament to Discuss Psilocybin Rescheduling

Psychedelic Bulletin #136: MindMed Collaborators Share Topline LSD for MDD Results; Oregon Issues Psilocybin Licences; UK Parliament to Discuss Psilocybin Rescheduling

Post published:April 28, 2023
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin #135: A Misguided MDMA Price-Fixing Effort; Psilocybin Study’s Lukewarm Results; Dutch Government Forms MDMA Commission; Trouble at Empyrean?

Psychedelic Bulletin #135: A Misguided MDMA Price-Fixing Effort; Psilocybin Study’s Lukewarm Results; Dutch Government Forms MDMA Commission; Trouble at Empyrean?

Post published:April 9, 2023
Post category:Psychedelic Bulletin

Read more about the article Dispatch from ECNP New Frontiers: Psychedelics (Psychedelic Bulletin #134)

Dispatch from ECNP New Frontiers: Psychedelics (Psychedelic Bulletin #134)

Post published:March 25, 2023
Post category:Psychedelic Bulletin

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.